Clinical Trial Update: [18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for [18F]THK-5351 PET imaging across Alzheimer's disease, mild cognitive impairment, and other neurodegenerative diseases; study c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Neurodegenerative Diseases

Drugs mentioned

• [18F]THK-5351

Snippet

Sponsor: Jae Seung Kim | Conditions: Alzheimer's Disease, Mild Cognitive Impairment | Phase 2 | Status: COMPLETED